HEADER TRANSFERASE 20-NOV-07 3BF5 TITLE CRYSTAL STRUCTURE OF PUTATIVE RIBOKINASE (10640157) FROM THERMOPLASMA TITLE 2 ACIDOPHILUM AT 1.91 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: RIBOKINASE RELATED PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: THERMOPLASMA ACIDOPHILUM DSM 1728; SOURCE 3 ORGANISM_TAXID: 273075; SOURCE 4 STRAIN: DSM 1728, AMRC-C165, IFO 15155, JCM 9062; SOURCE 5 ATCC: 25905; SOURCE 6 GENE: 10640157, TA0880; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS 10640157, PUTATIVE RIBOKINASE, STRUCTURAL GENOMICS, JOINT CENTER FOR KEYWDS 2 STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, KEYWDS 3 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 7 25-JAN-23 3BF5 1 SEQADV REVDAT 6 20-OCT-21 3BF5 1 REMARK SEQADV REVDAT 5 24-JUL-19 3BF5 1 REMARK LINK REVDAT 4 25-OCT-17 3BF5 1 REMARK REVDAT 3 13-JUL-11 3BF5 1 VERSN REVDAT 2 24-FEB-09 3BF5 1 VERSN REVDAT 1 04-DEC-07 3BF5 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF PUTATIVE RIBOKINASE (10640157) FROM JRNL TITL 2 THERMOPLASMA ACIDOPHILUM AT 1.91 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.91 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.91 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.19 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 46708 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2364 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.91 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.96 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3240 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.59 REMARK 3 BIN R VALUE (WORKING SET) : 0.3060 REMARK 3 BIN FREE R VALUE SET COUNT : 168 REMARK 3 BIN FREE R VALUE : 0.3170 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4352 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 214 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 36.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.33 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.39000 REMARK 3 B22 (A**2) : 0.30000 REMARK 3 B33 (A**2) : -2.69000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.168 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.155 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.137 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.130 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.940 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4570 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3071 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6183 ; 1.596 ; 1.952 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7485 ; 1.272 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 588 ; 3.758 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 200 ;31.909 ;23.800 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 755 ;12.183 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;14.311 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 671 ; 0.086 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5131 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 970 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 750 ; 0.167 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2926 ; 0.136 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2168 ; 0.158 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 2292 ; 0.072 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 191 ; 0.098 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 24 ; 0.081 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 62 ; 0.156 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 12 ; 0.113 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2982 ; 1.636 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1165 ; 0.450 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4546 ; 2.420 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1899 ; 4.387 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1623 ; 5.879 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 1 A 282 5 REMARK 3 1 B 1 B 282 5 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 1630 ; 0.250 ; 0.500 REMARK 3 LOOSE POSITIONAL 1 A (A): 1899 ; 0.380 ; 5.000 REMARK 3 MEDIUM THERMAL 1 A (A**2): 1630 ; 0.770 ; 2.000 REMARK 3 LOOSE THERMAL 1 A (A**2): 1899 ; 1.990 ;10.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 0 A 283 REMARK 3 ORIGIN FOR THE GROUP (A): 13.4670 34.8530 46.0250 REMARK 3 T TENSOR REMARK 3 T11: -0.2573 T22: -0.1808 REMARK 3 T33: -0.0527 T12: 0.0044 REMARK 3 T13: 0.0037 T23: 0.0292 REMARK 3 L TENSOR REMARK 3 L11: 1.5509 L22: 1.5413 REMARK 3 L33: 2.1719 L12: 0.1356 REMARK 3 L13: 0.6006 L23: 0.3147 REMARK 3 S TENSOR REMARK 3 S11: 0.0676 S12: -0.1361 S13: -0.0190 REMARK 3 S21: 0.1340 S22: -0.0118 S23: 0.0216 REMARK 3 S31: -0.0673 S32: -0.1845 S33: -0.0558 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1 B 263 REMARK 3 RESIDUE RANGE : B 267 B 282 REMARK 3 ORIGIN FOR THE GROUP (A): 8.1690 31.6550 -1.3790 REMARK 3 T TENSOR REMARK 3 T11: 0.0190 T22: -0.0429 REMARK 3 T33: -0.0162 T12: -0.0647 REMARK 3 T13: 0.0031 T23: -0.0158 REMARK 3 L TENSOR REMARK 3 L11: 0.2263 L22: 0.6340 REMARK 3 L33: 9.2717 L12: -0.3621 REMARK 3 L13: -0.1168 L23: 0.8964 REMARK 3 S TENSOR REMARK 3 S11: 0.0479 S12: 0.1053 S13: -0.0006 REMARK 3 S21: 0.0219 S22: 0.0693 S23: 0.0196 REMARK 3 S31: 0.6104 S32: -0.3880 S33: -0.1172 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. REMARK 3 2. ATOM RECORDS CONTAIN RESIDUAL B FACTORS ONLY. REMARK 3 3. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY REMARK 3 OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 REMARK 3 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. REMARK 3 4. 1,2-PROPANEDIOL (PGO) IS MODELED FROM THE CRYSTALLIZATION REMARK 3 CONDITION. REMARK 4 REMARK 4 3BF5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-NOV-07. REMARK 100 THE DEPOSITION ID IS D_1000045442. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-OCT-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91840, 0.97939, 0.97953 REMARK 200 MONOCHROMATOR : SI(111) DOUBLE CRYSTAL REMARK 200 OPTICS : ADJUSTABLE FOCUSING MIRRORS IN K REMARK 200 -B GEOMETRY REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46740 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.910 REMARK 200 RESOLUTION RANGE LOW (A) : 29.185 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.7800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.91 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.98 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.68500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NANODROP, 40.0% 1,2-PROPANEDIOL, 0.1M REMARK 280 ACETATE PH 4.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.22500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 88.82500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.59000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 88.82500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.22500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.59000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1960 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A -18 REMARK 465 GLY A -17 REMARK 465 SER A -16 REMARK 465 ASP A -15 REMARK 465 LYS A -14 REMARK 465 ILE A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 HIS A -9 REMARK 465 HIS A -8 REMARK 465 HIS A -7 REMARK 465 GLU A -6 REMARK 465 ASN A -5 REMARK 465 LEU A -4 REMARK 465 TYR A -3 REMARK 465 PHE A -2 REMARK 465 GLN A -1 REMARK 465 THR A 284 REMARK 465 LYS A 285 REMARK 465 ARG A 286 REMARK 465 SER A 287 REMARK 465 MSE B -18 REMARK 465 GLY B -17 REMARK 465 SER B -16 REMARK 465 ASP B -15 REMARK 465 LYS B -14 REMARK 465 ILE B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 HIS B -9 REMARK 465 HIS B -8 REMARK 465 HIS B -7 REMARK 465 GLU B -6 REMARK 465 ASN B -5 REMARK 465 LEU B -4 REMARK 465 TYR B -3 REMARK 465 PHE B -2 REMARK 465 GLN B -1 REMARK 465 GLY B 0 REMARK 465 ASN B 264 REMARK 465 PHE B 265 REMARK 465 SER B 266 REMARK 465 PHE B 283 REMARK 465 THR B 284 REMARK 465 LYS B 285 REMARK 465 ARG B 286 REMARK 465 SER B 287 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 23 CD NE CZ NH1 NH2 REMARK 470 LYS A 30 CD CE NZ REMARK 470 LYS A 49 CD CE NZ REMARK 470 ARG A 51 NH1 NH2 REMARK 470 GLU A 67 CD OE1 OE2 REMARK 470 LYS A 100 CG CD CE NZ REMARK 470 GLU A 121 CD OE1 OE2 REMARK 470 LYS A 138 CE NZ REMARK 470 GLU A 199 CG CD OE1 OE2 REMARK 470 ARG A 200 NE CZ NH1 NH2 REMARK 470 GLU A 263 CG CD OE1 OE2 REMARK 470 GLU A 270 CG CD OE1 OE2 REMARK 470 ARG A 280 NE CZ NH1 NH2 REMARK 470 ARG A 281 CD NE CZ NH1 NH2 REMARK 470 ARG B 2 NE CZ NH1 NH2 REMARK 470 ARG B 23 CZ NH1 NH2 REMARK 470 LYS B 30 CE NZ REMARK 470 LYS B 49 CD CE NZ REMARK 470 ARG B 51 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 67 CD OE1 OE2 REMARK 470 LYS B 100 CD CE NZ REMARK 470 GLN B 117 CG CD OE1 NE2 REMARK 470 ASP B 135 CG OD1 OD2 REMARK 470 LYS B 138 CE NZ REMARK 470 LYS B 157 CG CD CE NZ REMARK 470 LYS B 190 CE NZ REMARK 470 GLU B 199 CG CD OE1 OE2 REMARK 470 ARG B 200 CD NE CZ NH1 NH2 REMARK 470 ARG B 241 CZ NH1 NH2 REMARK 470 ASP B 260 CG OD1 OD2 REMARK 470 GLU B 263 CG CD OE1 OE2 REMARK 470 GLU B 270 CG CD OE1 OE2 REMARK 470 GLU B 273 CG CD OE1 OE2 REMARK 470 ARG B 274 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 277 CG CD OE1 OE2 REMARK 470 ASN B 278 CG OD1 ND2 REMARK 470 ARG B 280 NE CZ NH1 NH2 REMARK 470 ARG B 281 CG CD NE CZ NH1 NH2 REMARK 470 MSE B 282 CG SE CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 2 NE - CZ - NH1 ANGL. DEV. = 5.5 DEGREES REMARK 500 ARG A 2 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 10 76.33 -110.75 REMARK 500 SER A 128 -110.80 -106.25 REMARK 500 SER A 149 -135.37 54.92 REMARK 500 SER A 149 -133.65 52.14 REMARK 500 ASN A 197 51.97 -143.31 REMARK 500 LEU B 10 78.58 -108.79 REMARK 500 ALA B 119 -70.93 -66.54 REMARK 500 SER B 128 -115.89 -102.63 REMARK 500 PRO B 131 172.30 -55.39 REMARK 500 SER B 149 -133.51 55.93 REMARK 500 SER B 149 -134.11 56.98 REMARK 500 ASN B 197 52.47 -145.48 REMARK 500 ASP B 259 -75.37 -66.09 REMARK 500 ARG B 281 50.21 -96.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 B 288 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGO A 288 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGO B 289 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGO B 290 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGO A 289 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGO B 291 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGO A 290 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGO B 292 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 381882 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE CONSTRUCT WAS ENGINEERED WITH REMARK 999 THE FOLLOWING MUTATIONS: E112A, K113A, K115A. DBREF 3BF5 A 1 287 UNP Q9HJT3 Q9HJT3_THEAC 1 287 DBREF 3BF5 B 1 287 UNP Q9HJT3 Q9HJT3_THEAC 1 287 SEQADV 3BF5 MSE A -18 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 GLY A -17 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 SER A -16 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 ASP A -15 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 LYS A -14 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 ILE A -13 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 HIS A -12 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 HIS A -11 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 HIS A -10 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 HIS A -9 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 HIS A -8 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 HIS A -7 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 GLU A -6 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 ASN A -5 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 LEU A -4 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 TYR A -3 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 PHE A -2 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 GLN A -1 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 GLY A 0 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 ALA A 112 UNP Q9HJT3 GLU 112 ENGINEERED MUTATION SEQADV 3BF5 ALA A 113 UNP Q9HJT3 LYS 113 ENGINEERED MUTATION SEQADV 3BF5 ALA A 115 UNP Q9HJT3 LYS 115 ENGINEERED MUTATION SEQADV 3BF5 MSE B -18 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 GLY B -17 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 SER B -16 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 ASP B -15 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 LYS B -14 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 ILE B -13 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 HIS B -12 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 HIS B -11 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 HIS B -10 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 HIS B -9 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 HIS B -8 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 HIS B -7 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 GLU B -6 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 ASN B -5 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 LEU B -4 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 TYR B -3 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 PHE B -2 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 GLN B -1 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 GLY B 0 UNP Q9HJT3 EXPRESSION TAG SEQADV 3BF5 ALA B 112 UNP Q9HJT3 GLU 112 ENGINEERED MUTATION SEQADV 3BF5 ALA B 113 UNP Q9HJT3 LYS 113 ENGINEERED MUTATION SEQADV 3BF5 ALA B 115 UNP Q9HJT3 LYS 115 ENGINEERED MUTATION SEQRES 1 A 306 MSE GLY SER ASP LYS ILE HIS HIS HIS HIS HIS HIS GLU SEQRES 2 A 306 ASN LEU TYR PHE GLN GLY MSE ARG PHE LEU ALA TYR PHE SEQRES 3 A 306 GLY HIS LEU ASN ILE ASP VAL LEU ILE SER VAL ASP SER SEQRES 4 A 306 ILE PRO ARG GLU GLY SER VAL ASN VAL LYS ASP LEU ARG SEQRES 5 A 306 PRO ARG PHE GLY GLY THR ALA GLY ASN PHE ALA ILE VAL SEQRES 6 A 306 ALA GLN LYS PHE ARG ILE PRO PHE ASP LEU TYR SER ALA SEQRES 7 A 306 VAL GLY MSE LYS THR HIS ARG GLU TYR LEU ALA MSE ILE SEQRES 8 A 306 GLU SER MSE GLY ILE ASN THR GLY HIS VAL GLU LYS PHE SEQRES 9 A 306 GLU ASP GLU SER GLY PRO ILE CYS TYR ILE ALA THR ASP SEQRES 10 A 306 GLY LYS LYS GLN VAL SER PHE MSE HIS GLN GLY ALA MSE SEQRES 11 A 306 ALA ALA TRP ALA PRO GLN LEU ALA ASP GLU TYR GLU TYR SEQRES 12 A 306 VAL HIS PHE SER THR GLY PRO ASN TYR LEU ASP MSE ALA SEQRES 13 A 306 LYS SER ILE ARG SER LYS ILE ILE PHE ASP PRO SER GLN SEQRES 14 A 306 GLU ILE HIS LYS TYR SER LYS ASP GLU LEU LYS LYS PHE SEQRES 15 A 306 HIS GLU ILE SER TYR MSE SER ILE PHE ASN ASP HIS GLU SEQRES 16 A 306 TYR ARG VAL PHE ARG GLU MSE THR GLY LEU SER SER PRO SEQRES 17 A 306 LYS VAL THR THR ILE VAL THR ASN GLY GLU ARG GLY SER SEQRES 18 A 306 SER LEU PHE MSE ASP GLY LYS LYS TYR ASP PHE PRO ALA SEQRES 19 A 306 ILE PRO SER SER GLY ASP THR VAL GLY ALA GLY ASP SER SEQRES 20 A 306 PHE ARG ALA GLY LEU TYR LEU ALA LEU TYR ASN ARG ARG SEQRES 21 A 306 SER ILE GLU LYS GLY MSE ILE TYR GLY THR ILE ILE ALA SEQRES 22 A 306 HIS HIS VAL ILE ASP ASP GLY ILE GLU ASN PHE SER LEU SEQRES 23 A 306 ASN MSE GLU ASP LEU GLU ARG GLU THR GLU ASN TYR ARG SEQRES 24 A 306 ARG MSE PHE THR LYS ARG SER SEQRES 1 B 306 MSE GLY SER ASP LYS ILE HIS HIS HIS HIS HIS HIS GLU SEQRES 2 B 306 ASN LEU TYR PHE GLN GLY MSE ARG PHE LEU ALA TYR PHE SEQRES 3 B 306 GLY HIS LEU ASN ILE ASP VAL LEU ILE SER VAL ASP SER SEQRES 4 B 306 ILE PRO ARG GLU GLY SER VAL ASN VAL LYS ASP LEU ARG SEQRES 5 B 306 PRO ARG PHE GLY GLY THR ALA GLY ASN PHE ALA ILE VAL SEQRES 6 B 306 ALA GLN LYS PHE ARG ILE PRO PHE ASP LEU TYR SER ALA SEQRES 7 B 306 VAL GLY MSE LYS THR HIS ARG GLU TYR LEU ALA MSE ILE SEQRES 8 B 306 GLU SER MSE GLY ILE ASN THR GLY HIS VAL GLU LYS PHE SEQRES 9 B 306 GLU ASP GLU SER GLY PRO ILE CYS TYR ILE ALA THR ASP SEQRES 10 B 306 GLY LYS LYS GLN VAL SER PHE MSE HIS GLN GLY ALA MSE SEQRES 11 B 306 ALA ALA TRP ALA PRO GLN LEU ALA ASP GLU TYR GLU TYR SEQRES 12 B 306 VAL HIS PHE SER THR GLY PRO ASN TYR LEU ASP MSE ALA SEQRES 13 B 306 LYS SER ILE ARG SER LYS ILE ILE PHE ASP PRO SER GLN SEQRES 14 B 306 GLU ILE HIS LYS TYR SER LYS ASP GLU LEU LYS LYS PHE SEQRES 15 B 306 HIS GLU ILE SER TYR MSE SER ILE PHE ASN ASP HIS GLU SEQRES 16 B 306 TYR ARG VAL PHE ARG GLU MSE THR GLY LEU SER SER PRO SEQRES 17 B 306 LYS VAL THR THR ILE VAL THR ASN GLY GLU ARG GLY SER SEQRES 18 B 306 SER LEU PHE MSE ASP GLY LYS LYS TYR ASP PHE PRO ALA SEQRES 19 B 306 ILE PRO SER SER GLY ASP THR VAL GLY ALA GLY ASP SER SEQRES 20 B 306 PHE ARG ALA GLY LEU TYR LEU ALA LEU TYR ASN ARG ARG SEQRES 21 B 306 SER ILE GLU LYS GLY MSE ILE TYR GLY THR ILE ILE ALA SEQRES 22 B 306 HIS HIS VAL ILE ASP ASP GLY ILE GLU ASN PHE SER LEU SEQRES 23 B 306 ASN MSE GLU ASP LEU GLU ARG GLU THR GLU ASN TYR ARG SEQRES 24 B 306 ARG MSE PHE THR LYS ARG SER MODRES 3BF5 MSE A 1 MET SELENOMETHIONINE MODRES 3BF5 MSE A 62 MET SELENOMETHIONINE MODRES 3BF5 MSE A 71 MET SELENOMETHIONINE MODRES 3BF5 MSE A 75 MET SELENOMETHIONINE MODRES 3BF5 MSE A 106 MET SELENOMETHIONINE MODRES 3BF5 MSE A 111 MET SELENOMETHIONINE MODRES 3BF5 MSE A 136 MET SELENOMETHIONINE MODRES 3BF5 MSE A 169 MET SELENOMETHIONINE MODRES 3BF5 MSE A 183 MET SELENOMETHIONINE MODRES 3BF5 MSE A 206 MET SELENOMETHIONINE MODRES 3BF5 MSE A 247 MET SELENOMETHIONINE MODRES 3BF5 MSE A 269 MET SELENOMETHIONINE MODRES 3BF5 MSE A 282 MET SELENOMETHIONINE MODRES 3BF5 MSE B 1 MET SELENOMETHIONINE MODRES 3BF5 MSE B 62 MET SELENOMETHIONINE MODRES 3BF5 MSE B 71 MET SELENOMETHIONINE MODRES 3BF5 MSE B 75 MET SELENOMETHIONINE MODRES 3BF5 MSE B 106 MET SELENOMETHIONINE MODRES 3BF5 MSE B 111 MET SELENOMETHIONINE MODRES 3BF5 MSE B 136 MET SELENOMETHIONINE MODRES 3BF5 MSE B 169 MET SELENOMETHIONINE MODRES 3BF5 MSE B 183 MET SELENOMETHIONINE MODRES 3BF5 MSE B 206 MET SELENOMETHIONINE MODRES 3BF5 MSE B 247 MET SELENOMETHIONINE MODRES 3BF5 MSE B 269 MET SELENOMETHIONINE MODRES 3BF5 MSE B 282 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 62 8 HET MSE A 71 8 HET MSE A 75 8 HET MSE A 106 8 HET MSE A 111 8 HET MSE A 136 8 HET MSE A 169 8 HET MSE A 183 13 HET MSE A 206 8 HET MSE A 247 8 HET MSE A 269 13 HET MSE A 282 13 HET MSE B 1 8 HET MSE B 62 8 HET MSE B 71 8 HET MSE B 75 8 HET MSE B 106 8 HET MSE B 111 8 HET MSE B 136 8 HET MSE B 169 8 HET MSE B 183 13 HET MSE B 206 8 HET MSE B 247 8 HET MSE B 269 8 HET MSE B 282 5 HET PGO A 288 5 HET PGO A 289 5 HET PGO A 290 5 HET PO4 B 288 5 HET PGO B 289 5 HET PGO B 290 5 HET PGO B 291 5 HET PGO B 292 5 HETNAM MSE SELENOMETHIONINE HETNAM PGO S-1,2-PROPANEDIOL HETNAM PO4 PHOSPHATE ION FORMUL 1 MSE 26(C5 H11 N O2 SE) FORMUL 3 PGO 7(C3 H8 O2) FORMUL 6 PO4 O4 P 3- FORMUL 11 HOH *214(H2 O) HELIX 1 1 GLY A 38 PHE A 50 1 13 HELIX 2 2 HIS A 65 MSE A 75 1 11 HELIX 3 3 GLY A 109 TRP A 114 1 6 HELIX 4 4 ASN A 132 ILE A 140 1 9 HELIX 5 5 PRO A 148 TYR A 155 5 8 HELIX 6 6 SER A 156 SER A 167 1 12 HELIX 7 7 ASP A 174 GLY A 185 1 12 HELIX 8 8 GLY A 224 ASN A 239 1 16 HELIX 9 9 SER A 242 GLY A 261 1 20 HELIX 10 10 ASN A 268 PHE A 283 1 16 HELIX 11 11 GLY B 38 PHE B 50 1 13 HELIX 12 12 HIS B 65 MSE B 75 1 11 HELIX 13 13 GLN B 108 ALA B 113 5 6 HELIX 14 14 TYR B 133 ILE B 140 1 8 HELIX 15 15 PRO B 148 TYR B 155 5 8 HELIX 16 16 SER B 156 SER B 167 1 12 HELIX 17 17 ASP B 174 GLY B 185 1 12 HELIX 18 18 GLY B 198 ARG B 200 5 3 HELIX 19 19 GLY B 224 ASN B 239 1 16 HELIX 20 20 SER B 242 GLY B 261 1 20 HELIX 21 21 ASN B 268 ARG B 281 1 14 SHEET 1 A 9 VAL A 82 PHE A 85 0 SHEET 2 A 9 ASP A 55 GLY A 61 1 N VAL A 60 O PHE A 85 SHEET 3 A 9 ARG A 2 PHE A 7 1 N TYR A 6 O TYR A 57 SHEET 4 A 9 TYR A 122 PHE A 127 1 O HIS A 126 N PHE A 7 SHEET 5 A 9 LYS A 143 PHE A 146 1 O LYS A 143 N GLU A 123 SHEET 6 A 9 MSE A 169 ASN A 173 1 O ILE A 171 N PHE A 146 SHEET 7 A 9 THR A 193 ASN A 197 1 O THR A 196 N PHE A 172 SHEET 8 A 9 GLY A 201 MSE A 206 -1 O PHE A 205 N THR A 193 SHEET 9 A 9 LYS A 209 PRO A 214 -1 O PHE A 213 N SER A 202 SHEET 1 B 5 ASP A 31 GLY A 37 0 SHEET 2 B 5 ASN A 11 SER A 17 -1 N ASN A 11 O GLY A 37 SHEET 3 B 5 ILE A 92 THR A 97 1 O ILE A 95 N ILE A 16 SHEET 4 B 5 GLN A 102 HIS A 107 -1 O HIS A 107 N ILE A 92 SHEET 5 B 5 GLY B 25 ASN B 28 1 O VAL B 27 N MSE A 106 SHEET 1 C 5 GLY A 25 ASN A 28 0 SHEET 2 C 5 GLN B 102 HIS B 107 1 O MSE B 106 N VAL A 27 SHEET 3 C 5 ILE B 92 THR B 97 -1 N ILE B 92 O HIS B 107 SHEET 4 C 5 ASN B 11 SER B 17 1 N VAL B 14 O CYS B 93 SHEET 5 C 5 ASP B 31 GLY B 37 -1 O GLY B 37 N ASN B 11 SHEET 1 D 9 VAL B 82 PHE B 85 0 SHEET 2 D 9 PHE B 54 GLY B 61 1 N SER B 58 O GLU B 83 SHEET 3 D 9 ARG B 2 PHE B 7 1 N TYR B 6 O TYR B 57 SHEET 4 D 9 TYR B 122 PHE B 127 1 O HIS B 126 N PHE B 7 SHEET 5 D 9 LYS B 143 PHE B 146 1 O LYS B 143 N GLU B 123 SHEET 6 D 9 MSE B 169 ASN B 173 1 O ILE B 171 N PHE B 146 SHEET 7 D 9 THR B 193 THR B 196 1 O THR B 196 N PHE B 172 SHEET 8 D 9 SER B 202 MSE B 206 -1 O PHE B 205 N THR B 193 SHEET 9 D 9 LYS B 209 PHE B 213 -1 O PHE B 213 N SER B 202 LINK C GLY A 0 N MSE A 1 1555 1555 1.34 LINK C MSE A 1 N ARG A 2 1555 1555 1.33 LINK C GLY A 61 N MSE A 62 1555 1555 1.33 LINK C MSE A 62 N LYS A 63 1555 1555 1.34 LINK C ALA A 70 N MSE A 71 1555 1555 1.33 LINK C MSE A 71 N ILE A 72 1555 1555 1.32 LINK C SER A 74 N MSE A 75 1555 1555 1.34 LINK C MSE A 75 N GLY A 76 1555 1555 1.34 LINK C PHE A 105 N MSE A 106 1555 1555 1.34 LINK C MSE A 106 N HIS A 107 1555 1555 1.34 LINK C ALA A 110 N MSE A 111 1555 1555 1.33 LINK C MSE A 111 N ALA A 112 1555 1555 1.34 LINK C ASP A 135 N MSE A 136 1555 1555 1.34 LINK C MSE A 136 N ALA A 137 1555 1555 1.33 LINK C TYR A 168 N MSE A 169 1555 1555 1.34 LINK C MSE A 169 N SER A 170 1555 1555 1.33 LINK C GLU A 182 N MSE A 183 1555 1555 1.35 LINK C MSE A 183 N THR A 184 1555 1555 1.34 LINK C PHE A 205 N MSE A 206 1555 1555 1.33 LINK C MSE A 206 N ASP A 207 1555 1555 1.33 LINK C GLY A 246 N MSE A 247 1555 1555 1.33 LINK C MSE A 247 N ILE A 248 1555 1555 1.33 LINK C ASN A 268 N MSE A 269 1555 1555 1.33 LINK C MSE A 269 N GLU A 270 1555 1555 1.34 LINK C ARG A 281 N MSE A 282 1555 1555 1.34 LINK C MSE A 282 N PHE A 283 1555 1555 1.34 LINK C MSE B 1 N ARG B 2 1555 1555 1.34 LINK C GLY B 61 N MSE B 62 1555 1555 1.33 LINK C MSE B 62 N LYS B 63 1555 1555 1.33 LINK C ALA B 70 N MSE B 71 1555 1555 1.34 LINK C MSE B 71 N ILE B 72 1555 1555 1.33 LINK C SER B 74 N MSE B 75 1555 1555 1.34 LINK C MSE B 75 N GLY B 76 1555 1555 1.34 LINK C PHE B 105 N MSE B 106 1555 1555 1.34 LINK C MSE B 106 N HIS B 107 1555 1555 1.34 LINK C ALA B 110 N MSE B 111 1555 1555 1.34 LINK C MSE B 111 N ALA B 112 1555 1555 1.34 LINK C ASP B 135 N MSE B 136 1555 1555 1.34 LINK C MSE B 136 N ALA B 137 1555 1555 1.34 LINK C TYR B 168 N MSE B 169 1555 1555 1.34 LINK C MSE B 169 N SER B 170 1555 1555 1.33 LINK C GLU B 182 N MSE B 183 1555 1555 1.34 LINK C MSE B 183 N THR B 184 1555 1555 1.33 LINK C PHE B 205 N MSE B 206 1555 1555 1.34 LINK C MSE B 206 N ASP B 207 1555 1555 1.34 LINK C GLY B 246 N MSE B 247 1555 1555 1.33 LINK C MSE B 247 N ILE B 248 1555 1555 1.33 LINK C ASN B 268 N MSE B 269 1555 1555 1.33 LINK C MSE B 269 N GLU B 270 1555 1555 1.34 LINK C ARG B 281 N MSE B 282 1555 1555 1.34 CISPEP 1 GLY A 90 PRO A 91 0 1.21 CISPEP 2 GLY B 90 PRO B 91 0 1.90 SITE 1 AC1 7 ARG A 241 SER A 242 LYS A 245 ARG B 241 SITE 2 AC1 7 SER B 242 LYS B 245 HOH B 358 SITE 1 AC2 6 GLN A 108 MSE A 111 ALA A 112 GLY A 130 SITE 2 AC2 6 GLU A 151 LYS A 154 SITE 1 AC3 3 THR B 64 SER B 89 HOH B 301 SITE 1 AC4 4 MSE B 62 GLU B 73 ASP B 271 ARG B 274 SITE 1 AC5 4 GLN A 150 ASN A 173 HIS A 175 GLU A 176 SITE 1 AC6 5 PRO B 189 MSE B 206 ASP B 207 GLY B 208 SITE 2 AC6 5 HOH B 355 SITE 1 AC7 6 THR A 196 GLY A 198 GLY A 201 PHE A 229 SITE 2 AC7 6 HOH A 295 HOH A 406 SITE 1 AC8 5 TYR B 168 THR B 192 MSE B 206 ILE B 243 SITE 2 AC8 5 HOH B 356 CRYST1 56.450 59.180 177.650 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017715 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016898 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005629 0.00000